Cannabis Testing Market Size, Share, Growth Analysis, By Technology(Chromatography, Liquid chromatography, Gas chromatography, Spectroscopy), By Test(Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing), By End User(Laboratories, Cannabis Cultivators and Growers, Cannabis Drug Manufacturers and Dispensaries, and Others), By Region - Industry Forecast 2024-2031

Global Cannabis Testing Market size was valued at USD 7 Billion in 2022 and is poised to grow from USD 7.9 Billion in 2023 to USD 21.9 Billion by 2031, growing at a CAGR of 13.5% in the forecast period (2024-2031).

The utilization of cannabis extracts in treating numerous neurological and mental disorders has surged alongside the rise in both the prevalence and production of cannabis. This escalating trend is expected to fuel substantial growth in the cannabis testing market over the forecast period. According to the European Brain Council, there are approximately 600 reported neurological disorders worldwide, positioning mental disorders among the leading causes of global ill-health and disability.

Notably, depression stands out as the most prevalent mental disorder, affecting over 264 million individuals of all ages globally, with a higher incidence among women. This growing prevalence underscores the significance of cannabis testing in evaluating the efficacy and safety of cannabis-based treatments. Additionally, the increasing recognition and adoption of software services within laboratories conducting cannabis testing serve as pivotal factors propelling the market's expansion, enhancing testing capabilities and accuracy in analyzing cannabis-related products.